Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00240487 · ClinicalTrials.gov registry record · Phase 3
Nitric Oxide Administration for Acute Respiratory Distress Syndrome
A Phase 3 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 3
- Development phase
- 52
- Enrollment target
NCT00240487 is a Phase 3 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 52 participants.
The verdict
NCT00240487, a Phase 3 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 52 participants
- Enrollment target
Study Summary
This research project is an open-label, randomized study for the use of Nitric Oxide in pediatric patients with acute respiratory distress syndrome (ARDS). The study examines whether nitric oxide (NO) treatment impacts the the P:F ratio (arterial partial pressure of oxygen (PaO2) divided by fraction of inspired oxygen (FiO2) in patients with ARDS. The goal of the study is to evaluate whether the order of NO therapy will have any effect on response, and evaluate the characteristics of patients who respond to NO compared to those who do not.
Interventions
- OTHER No Intervention
- DRUG Nitric Oxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2000-09 |
| Est. Completion | 2008-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00240487
The ClinicalTrials.gov registry entry for NCT00240487 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which No Intervention is the first listed.
NCT00240487 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00240487 about?
NCT00240487 is a clinical study titled "Nitric Oxide Administration for Acute Respiratory Distress Syndrome". This research project is an open-label, randomized study for the use of Nitric Oxide in pediatric patients with acute respiratory distress syndrome (ARDS). The study examines whether nitric oxide (NO) treatment impacts the the P:F ratio (arterial partial pressure of oxygen (PaO2) divided by fraction...
What is the current status of trial NCT00240487?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 52 participants. The study started on 2000-09. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00240487?
The interventions under investigation include: No Intervention (OTHER), Nitric Oxide (DRUG).
Who is sponsoring clinical trial NCT00240487?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.